Study: MUSE System Reduces PPI Use in 85% of Patients
presented a study on its MUSE system.
The study examined the system's efficacy as a trans-oral treatment for gastroesophageal reflux disease. The study found:
• 85 percent of GERD patients reduced proton pump inhibitor use by 50 percent or more
• Of these patients, 65 percent were able to eliminate medication use after six months
• 73 percent of patients reported improved quality of life scores of 50 percent or more
More Articles on Gastroenterology:
Adenoma Detection Rate: Lowering Colorectal Cancer Risk
12 Gastroenterologist Moves & Honors
Defining Leadership in the GI Field: 2 Gastroenterologists Discuss Their Strategies
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
New from Becker's ASC Review
Annie Penn Hospital to Spend $2.2M to Expand Endoscopy ServicesRead Now
- 8 Endoscopy Center Administrators to Know
- 20 Statistics on ASC vs. HOPD Medicare Patient Characteristics
- Transaction Tip of the Day: When is the Right Time to Sell?
- Drs. Harjit Bhogal, Arushi deFonseka Join Capital Digestive Care
- Birmingham Gastroenterology Associates Partner With Baptist Health System